These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 11419841

  • 1. Prognostic value of hepatocyte proliferative activity after transjugular intrahepatic portosystemic shunt.
    Delhaye M, Le Moine O, Degraef C, Devière J, Galand P.
    Am J Gastroenterol; 2001 Jun; 96(6):1866-71. PubMed ID: 11419841
    [Abstract] [Full Text] [Related]

  • 2. Relationship between hepatocyte proliferative activity and liver functional reserve in human cirrhosis.
    Delhaye M, Louis H, Degraef C, Le Moine O, Devière J, Gulbis B, Jacobovitz D, Adler M, Galand P.
    Hepatology; 1996 May; 23(5):1003-11. PubMed ID: 8621125
    [Abstract] [Full Text] [Related]

  • 3. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F, Baez AL, Pandula R, Walser E, Lau DT.
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [Abstract] [Full Text] [Related]

  • 4. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Mar; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 5. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T, Safka V, Hůlek P, Vanásek T, Krajina A, Jirkovský V.
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [Abstract] [Full Text] [Related]

  • 6. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M, Dufresne MP, Bui B, Fenyves D, Spahr L, Roy L, Lafortune M, Pomier-Layrargues G.
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [Abstract] [Full Text] [Related]

  • 7. [Indicators for longterm survival after the transjugular portosystemic intrahepatic shunt procedure].
    Kirchhoff TD, Rosenthal H, Merkesdal S, Ockenga J, Manns MP, Galanski M, Caselitz M.
    Radiologe; 2002 Sep; 42(9):745-52. PubMed ID: 12244477
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D, Patch D, Dick R, Grosso M, Rousseau H, Otal P, Goffette P, Heinecke A, Drees M, Domschke W, Menzel J.
    Cardiovasc Intervent Radiol; 2002 Sep; 25(6):506-12. PubMed ID: 12183763
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transjugular intrahepatic portosystemic shunts for refractory ascites after liver transplantation.
    Abouljoud M, Yoshida A, Kim D, Jerius J, Arenas J, Raoufi M, Brown K, Moonka D.
    Transplant Proc; 2005 Mar; 37(2):1248-50. PubMed ID: 15848685
    [Abstract] [Full Text] [Related]

  • 14. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting.
    Wallace MJ, Madoff DC, Ahrar K, Warneke CL.
    Cancer; 2004 Jul 15; 101(2):337-45. PubMed ID: 15241832
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LJ, Abu-Elmagd K, Connor J, DIVERT Study Group.
    Gastroenterology; 2006 May 15; 130(6):1643-51. PubMed ID: 16697728
    [Abstract] [Full Text] [Related]

  • 17. Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.
    Russo MW, Sood A, Jacobson IM, Brown RS.
    Am J Gastroenterol; 2003 Nov 15; 98(11):2521-7. PubMed ID: 14638358
    [Abstract] [Full Text] [Related]

  • 18. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
    Harrod-Kim P, Saad WE, Waldman D.
    J Vasc Interv Radiol; 2006 Oct 15; 17(10):1605-10. PubMed ID: 17057001
    [Abstract] [Full Text] [Related]

  • 19. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts.
    Rössle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K.
    Am J Gastroenterol; 2001 Dec 15; 96(12):3379-83. PubMed ID: 11774952
    [Abstract] [Full Text] [Related]

  • 20. Correlation between increased colloid osmotic pressure and the resolution of refractory ascites after transjugular intrahepatic portosystemic shunt.
    Schiano TD, Black M, Hills C, Ter H, Bellary S, Miller LS.
    South Med J; 2000 Mar 15; 93(3):305-9. PubMed ID: 10728519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.